home / stock / pmd / pmd news

PMD News and Press, Psychemedics Corporation From 11/09/22

Stock Information
Company Name: Psychemedics Corporation
Stock Symbol: PMD
Market: NASDAQ
Website: psychemedics.com
Menu
PMD PMD Quote PMD Short PMD News PMD Articles PMD Message Board
Get PMD Alerts

News, Short Squeeze, Breakout and More Instantly...
PMD - Psychemedics Corporation Reports Third Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the third quarter ended September 30, 2022. The Company also announced a cash quarterly divid...
PMD - Psychemedics GAAP EPS of -$0.06, revenue of $6.51M

Psychemedics press release ( NASDAQ: PMD ): Q2 GAAP EPS of -$0.06. Revenue of $6.51M (+6.9% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.06, revenue of $6.51M

PMD - Psychemedics Corporation Reports Second Quarter 2022 Financial Results and Declares Quarterly Cash Dividend

ACTON, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the second quarter ended June 30, 2022. The Company also announced a quarterly dividend of $0...

PMD - Psychemedics Announces Two New Director Nominees for its 2022 Annual Meeting of Stockholders and Director Walter S. Tomenson, Jr.'s Retirement after More than 20 Years of Dedicated Service

ACTON, Mass., June 09, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced today that it will be nominating Peter H. Kamin and Darius G. Nevin to serve as new members of its Board of Directors at its upcoming Annual Meeting of Stockholders to be held on Augus...
PMD - Psychemedics raises dividend by 40% to $0.07

Psychemedics (PMD) declares $0.07/share quarterly dividend, 40% increase from prior dividend of $0.05. Forward yield 4.56% Payable June 24; for shareholders of record May 27; ex-div May 26. See PMD Dividend Scorecard, Yield Chart, & Dividend Growth. For further details see: Psycheme...

PMD - Psychemedics GAAP EPS of $0.01, revenue of $6.5M

Psychemedics press release (NASDAQ:PMD): Q1 GAAP EPS of $0.01. Revenue of $6.5M (+14.0% Y/Y). For further details see: Psychemedics GAAP EPS of $0.01, revenue of $6.5M

PMD - Psychemedics Corporation Reports First Quarter 2022 Financial Results and Declares Increased Cash Dividend

ACTON, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, today announced financial results for the first quarter ended March 31, 2022, and the declaration of a cash dividend of $0.07 per sh...
PMD - Psychemedics: 21% Sales Growth But Net Loss, Takeover Possibility, Covid Recovery Play

21% YoY revenue growth in Q4, gross margins surge 1,000bps YoY. EPS loss of $0.29 on higher legal costs and a one-time expense. Company paid a dividend of $0.05/share in December and is evaluating options for 2022. 11% FCF yield on “normal” 2023 estimates. Ma...

PMD - Psychemedics GAAP EPS of -$0.29, revenue of $6.44M

Psychemedics press release (NASDAQ:PMD): Q4 GAAP EPS of -$0.29. Revenue of $6.44M (+20.6% Y/Y). For further details see: Psychemedics GAAP EPS of -$0.29, revenue of $6.44M

PMD - Psychemedics Corporation Reports Fourth Quarter and Full Year 2021 Financial Results

ACTON, Mass., March 29, 2022 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s largest provider of hair testing for drugs of abuse, announced today fourth quarter and full year financial results for the period ended December 31, 2021. The Company’s re...
Previous 10 Next 10